Lv22
105 积分 2022-07-19 加入
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
1小时前
待确认
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
7小时前
已完结
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
8小时前
已完结
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
15小时前
已完结
Abstract LB006: PC14586: The first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development
12天前
已完结
Multiple Peaking Phenomena in Pharmacokinetic Disposition
13天前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
13天前
已完结
Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists
16天前
已完结
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists
18天前
已完结
Potent, orally absorbed glucagon receptor antagonists
18天前
已完结
皖公网安备34019202002308
